Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells.

[1]  Makoto Naito,et al.  Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.

[2]  A. von Eckardstein,et al.  Mast Cell Tryptase Degrades HDL and Blocks Its Function as an Acceptor of Cellular Cholesterol , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[3]  A. Hamsten,et al.  Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. , 2002, The American journal of pathology.

[4]  A. Tall,et al.  ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein* , 2001, The Journal of Biological Chemistry.

[5]  S. Yokoyama.  Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body. , 2000, Biochimica et biophysica acta.

[6]  P. Kovanen,et al.  Plasmin and kallikrein reduce HDL-induced cholesterol efflux from foam cells. , 2000, Biochemical and biophysical research communications.

[7]  S. Weiss,et al.  Regulation of Elastinolytic Cysteine Proteinase Activity in Normal and Cathepsin K–Deficient Human Macrophages , 2000, The Journal of experimental medicine.

[8]  A. Vaughan,et al.  ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. , 2000, Current opinion in lipidology.

[9]  S. Harvey,et al.  Structure and function of apolipoprotein A-I and high-density lipoprotein , 2000, Current opinion in lipidology.

[10]  D. Brömme,et al.  Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. , 2000, Biochemistry.

[11]  Anthony E. Klon,et al.  A Detailed Molecular Belt Model for Apolipoprotein A-I in Discoidal High Density Lipoprotein* , 1999, The Journal of Biological Chemistry.

[12]  P. Libby,et al.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms. , 1999, The Journal of clinical investigation.

[13]  A. Vaughan,et al.  The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. , 1999, The Journal of clinical investigation.

[14]  A. Jonas,et al.  Structural organization of the N-terminal domain of apolipoprotein A-I: studies of tryptophan mutants. , 1999, Biochemistry.

[15]  P. Kovanen,et al.  Matrix Metalloproteinases-3, -7, and -12, but Not -9, Reduce High Density Lipoprotein-induced Cholesterol Efflux from Human Macrophage Foam Cells by Truncation of the Carboxyl Terminus of Apolipoprotein A-I , 1999, The Journal of Biological Chemistry.

[16]  A. von Eckardstein,et al.  Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[17]  H. Chapman,et al.  Human Cathepsin F , 1998, The Journal of Biological Chemistry.

[18]  P. Libby,et al.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. , 1998, The Journal of clinical investigation.

[19]  James C. Phillips,et al.  Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks. , 1997, Biophysical journal.

[20]  M. Mcgrath,et al.  Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex , 1997, Protein science : a publication of the Protein Society.

[21]  S. Weiss,et al.  Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Fielding,et al.  Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.

[23]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[24]  C. Peters,et al.  Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme. , 1993, The Journal of biological chemistry.

[25]  C. Fielding,et al.  Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. , 1988, Biochemistry.

[26]  P. Henson,et al.  Protein synthesis-dependent and protein synthesis-independent secretion of lysosomal hydrolases from rabbit and human macrophages. , 1982, Journal of the Reticuloendothelial Society.

[27]  M. Baggiolini,et al.  Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages , 1978, The Journal of experimental medicine.

[28]  M. Brown,et al.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Brown,et al.  Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Scanu.  Forms of human serum high density lipoprotein protein. , 1966, Journal of lipid research.

[31]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[32]  J. Kane,et al.  Pre-beta high density lipoprotein. Unique disposition of apolipoprotein A-I increases susceptibility to proteolysis. , 1990, Arteriosclerosis.

[33]  P. Kovanen.  Atheroma formation: defective control in the intimal round-trip of cholesterol. , 1990, European heart journal.

[34]  V. Clavey,et al.  Anion-exchange fast protein liquid chromatographic characterization and purification of apolipoproteins A-I, A-II, C-I, C-II, C-III0, C-III1, C-III2 and E from human plasma. , 1987, Journal of chromatography.

[35]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[36]  A. Barrett,et al.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. , 1982, The Biochemical journal.